Company: MIRM
Filing Date: 2025-12-19
Form Type: 8-K
Source: 0001193125-25-325825
Chunk: 1

Company: Mirum Pharmaceuticals, Inc.
Filing Date: 2025-12-19
Form: 8-K
Item: Item 1.01
Chunk 1
---
 has agreed to prepare and file a registration statement with the U. S. Securities and Exchange Commission (the “ SEC”) to register for resale the PIPE Shares. The Company has agreed to be responsible for all fees and expenses incurred in connection with the registration of the PIPE Shares.

The Company has granted the PIPE Investors customary indemnification rights in connection with the registration statement. The PIPE Investors have also granted the Company customary indemnification rights in connection with the registration statement.

The foregoing descriptions of the Subscription Agreement and the Registration Rights Agreement do not purport to be complete and are subject to, and qualified in their entirety by, the full text of the form of Subscription Agreement and the form of Registration Rights Agreement, which are filed as Exhibit 10.1 and Exhibit 10.2, respectively, to this Current Report on Form8-K(this “ Form8-K”)and are incorporated herein by reference.